Shareholder Trends in Public Biotech Companies
Shareholder trends in public biotech companies are undergoing a notable shift as capital markets recalibrate expectations around innovation timelines, regulatory risk, and commercial execution. In the United States, where biotech firms frequently rely on public markets to fund clinical development, investor composition and behavior have become key indicators of sector health. Institutional investors, retail participants, … Read more